Do you have a BMI of >25? Or perhaps >30? If so, you are in good company.
Obesity is a killer, especially in the face of infection with COVID-19. As BMI rises, so does your risk of severe COVID infection, and death.
Theres never been a better time to lose weight, once and for all. Being overweight has many physical and psychological consequences. Are you in denial about your weight? When did you last work out your BMI?
Read on and find out the reason why losing weight right now is so important.
In July 2020, Public Health England produced a detailed report on all the relevant, up-to-date information about obesity and COVID-19. Much of the information here derives from this report.
Obesity, even without COVID infection, has serious effects on your health
Obesity has now been classified by the American Medical Association as a disease, not just a lifestyle factor.
Being obese is not a question of being lazy and greedy. Its a real medical condition that deserves just as much attention, understanding, and support as any other medical condition.
Obesity increases the risk of high blood pressure, heart attack, stroke, heart failure, type-2 diabetes, non-alcoholic liver disease, and various types of cancer.
These medical conditions occur far more often in people hospitalized with severe COVID infection, leading experts to believe that obesity is a common underlying factor.
Lets consider the following statements
In a recent study, (Yates, 2020) using data from the UK Biobank, the authors demonstrated the risk of COVID-19 infection increased as both BMI and waist circumference increased. Being overweight, obese, or severely obese, increased the risk of COVID infection by 31%, 55%, and 57%, respectively.
Hamer 2020 also studied data from 387,019 members of the UK biobank and calculated that being overweight (BMI/25), or obese (BMI>30), increased the risk of being admitted to hospital from COVID infection by 32%, and 97%, respectively.
A recent (May 2020) New York study in the British Medical Journal (BMJ) reported that people with obesity (BMI of >30), and severe obesity (BMI >40), were 4, and 6 times respectively, more likely to be admitted to hospital with COVID infection, than those with a BMI <30.
A systematic review and meta-analysis (Yang 2020), published in the Journal of Virology, concluded obesity increased the risk of severe COVID infection by a factor of 2.5, and the risk of a poor outcome by a factor of 2.3.
A meta-analysis published in the journal Obesity, Research and Clinical Practice (Hussain 2020), including results from 14 studies of 403,535 patients, concluded that compared to those with a normal BMI, obesity (BMI >25) doubled the risk of being critically ill, almost quadrupled the risk of death, and the risk of needing respiratory support was increased almost 7 times.
Many studies have reported an increased risk of death from COVID with increasing BMI.
For example, in May 2020 the British Medical Journal published a study of 20,133 patients admitted to 208 UK hospitals with COVID-19. Obesity (BMI>30) increased the risk of death by 33%.
There are many possible reasons why obesity increases your risk from COVID-19. These reasons were described in the journal Molecular Medicine Reports Petrakis, (May 2020).
Here is an explanation of their key findings its a bit technical Im afraid, but Ive simplified it the best I can
Obesity is known to impair immunity to other respiratory viruses, such as influenza, and reduces the response to the influenza vaccine (Green, 2017).
High blood glucose, and diabetes, both associated with obesity, have also been linked to increased morbidity and mortality from infections with other coronaviruses, for example, those causing the Severe Acute Respiratory Syndrome (SARS) outbreak in 2003, and the Middle Eastern Respiratory Syndrome (MERS) outbreak in 2012.
Being obese results in impaired lung function. There is increased fat deposition in the chest wall, the chest cavity (thorax), and the abdominal cavity (under the diaphragm) meaning that that in those who are obese, the chest is relatively compressed. Even without COVID-19 infection, obese individuals are working harder to maintain normal breathing.
COVID-19 enters the body through ACE2 receptors, found predominantly in the lung, and kidney, but also in the heart, and blood vessel walls. Activation of these receptors is integral in the control of blood pressure, as well as many other functions including the immune response, and regulating the process of inflammation.
Obesity is associated with chronic inflammation. Indeed, those with higher BMI levels often have metabolic syndrome a medical condition in which various metabolic processes are deranged, and which further increase the risk of atherosclerosis, and systemic (whole-body) inflammation. When you are obese, if you become infected with COVID-19, at the point of infection, your immune system is already over-activated.
In an obese person, when COVID-19 blocks your ACE2 receptors, your ACE1 receptors become relatively over-stimulated. This results in an outpouring of inflammatory cytokines (cell-signalling molecules) as the immune system goes into overdrive known as a cytokine storm.
In a cytokine storm, your lungs are overwhelmed with these cytokines, whose job it is to kill infected cells. The huge number of cytokines is so great, that instead of helping defend your body from infection, they destroy lung tissue. The air sacs in the lungs become filled with fluid, fluid, meaning oxygen cannot pass freely not the bloodstream and carbon dioxide cannot easily be excreted. This condition is called Acute Respiratory Distress Syndrome (ARDS).
This means people who are overweight or obese, have a higher risk of severe lung disease, requiring hospital admission, critical care, and mechanical ventilation. The CDC reports that the risk of death is ten times higher from COVID-19 infection, in people with metabolic syndrome and type-2 diabetes.
ACE2 receptors are also found in the islet cells of the pancreas. It has been suggested that COVID-19 may enter these islet cells, temporarily preventing the production of insulin, raised blood sugar, and causing type-2 diabetes. This may explain why people who are already diabetic, are especially vulnerable to COVID-19 infection.
With increasing obesity, your body becomes less sensitive to the hormone insulin. This is known as insulin resistance. In fact, as glucose levels rise, more and more insulin is produced, but your cells have difficulty recognizing and responding. Eventually, blood glucose levels can no longer be kept under control this is prediabetes. In due course, if no steps are taken, full-blown diabetes sets in.
Insulin resistance is harmful as it underpins the development of many different medical conditions.
The exact reasons insulin resistance worsens the prognosis of COVID-19 infection are still not fully understood. However, activation of the ACE2 receptor is known to enhance insulin signalling and reduce insulin resistance. COVID-19 attaches to the same receptors and may blunt this activity. More research is needed.
Adipocytes (fat cells) produce a hormone called leptin. This is a hormone that regulates appetite. High leptin levels make you feel full and help to stop you from eating. It also increases your energy expenditure.
Strangely, obese people tend to have higher leptin levels, probably due to leptin resistance. As a result, even though leptin levels are high, they still have a large appetite. High leptin levels accelerate atherosclerosis, causing damage to endothelial cells and lowering HDL (good) cholesterol.
Leptin is a cell-signalling molecule, which itself triggers the production of inflammatory cytokines (interleukins 2 and 6, and tumour necrosis factor) and sets off the inflammation cascade.
The good news is that leptin levels fall with weight reduction.
Many studies have shown that people who are obese tend to have an unhealthy diet eating large amounts of fast food and processed food. These are often high-fat, high-protein, high-salt, low- fibre, low in complex carbohydrates (carbs which release energy slowly), and low in vitamin D. These foods may also be contaminated with pesticides.
This diet causes changes to the gut microbiome, increasing the leakiness of the gut wall. This means the junctions between intestinal cells are weakened, such that bacteria, viruses, and toxins can pass from the gut contents into the bloodstream. These effects then further exacerbate systemic inflammation.
There is also a link between the unhealthy Western diet and autoimmune diseases. High-salt increases the risk of high blood pressure, cardiovascular disease, and stroke.
Fat is not an inactive tissue. In fact, visceral fat produces large numbers of cytokines, such as Interleukin 6 (IL-6), and tumour necrosis factor- (TNF-). IL-6 has several important roles, for example in the regulation of B and T lymphocytes. TNF- regulates many aspects of immune function, for example, to cause cell death and destruction.
In addition, eating a high-fat diet has been shown to increase the production of these cytokines.
Too much dietary fat can literally poison your organs. Lipotoxicity occurs when there is so much dietary fat, that adipocytes (fat cells) cannot store any more, and the excess fat spills over into the bloodstream. Free fatty acids are then stored in other tissues such as the liver, heart, and kidneys. These fats are toxic and cause organ damage, for example, non-alcoholic liver disease, heart failure, and kidney failure.
Lipotoxicity is also associated with insulin and leptin resistance.
Oxidative stress is another type of metabolic derangement, in which electrically charged particles called reactive oxygen species (ROS), cause tissue destruction.
Obesity increases oxidative stress. As a result, there is an increased breakdown of lipids in the walls of red blood cells, meaning these red cells, carrying vital haemoglobin, are less able to squeeze through microcapillaries, and release oxygen as they should.
Increased oxidative stress seems also to increase damage to the air sacs in the lungs, the alveoli, and to stimulates coagulation, leading to an increase in microvascular thrombosis.
Obesity seems to increase general susceptibility to infection. Some have suggested that COVID-19 may even use excess adipose tissue as a reservoir where it can replicate, and to facilitate viral shedding, and enhance transmission of infection.
There is some evidence that people living with obesity have worse COVID symptoms than those with a normal BMI.
In obesity, there is increased fat deposition in the heart muscle, but the effects on the heart are further compounded as obesity is also associated with high blood pressure, metabolic syndrome, and diabetes.
In the heart, obesity results in obesity-related cardiomyopathy, with enlargement and fat deposition in cardiac muscle cells. Obesity is liked to sleep apnoea, meaning the heart is relatively under-perfused with oxygen during sleep.
If you are obese, there are numerous biochemical and metabolic reasons why COVID-19 infection is more likely to be severe and have a poor outcome. This is due to a combination of factors.
Are you convinced? Its all pretty scary. But heres the good news losing weight will reverse many of these parameters and help keep you well. Whats stopping you? The time is now.
You dont need to have unrealistic targets. Just losing 5% of your body weight will reduce insulin resistance and relieve oxidative stress. Even a mere 5% weight loss has major health benefits.
For example, if you weigh 100kg, 5% is 5kg (11 lb).
If you lose 2lb a week you can lose this in just 5-6 weeks.
And there are so many benefits of losing weight quite apart from improving your chances from COVID.
Obesity and COVID-19 are a double pandemic. Its a frightening reality.
However, now you know the facts, you can make up your mind right now, to change things for the better. Dont let the virus win!
Why not see your GP and discuss ways you can lose weight, and what support is available? There are many different weight-losing diets, but if you have a lot of weight to lose, you can take weight loss medication, or be referred for bariatric surgery. Why not find out what you can do and get started right away?
For more information
Editor's Recommended Articles
Read the original post:
What do we know about obesity and COVID-19? - Open Access Government
- Exercise promotes a molecular profile in muscle: Research - January 21st, 2023
- Molecular Diagnostics Laboratory < Laboratory Medicine - January 4th, 2023
- Molecular cloning - Wikipedia - December 18th, 2022
- Trends in Molecular Medicine | Journal - ScienceDirect - December 10th, 2022
- Researchers from Insilico Medicine, University of Copenhagen, and University of Chicago unravel molecular secrets hidden in premature aging diseases... - December 2nd, 2022
- Nuclear Medicine and Molecular Imaging Week: October 2-8, 2022 - October 29th, 2022
- Biochemistry & Molecular Biology | Medicine - October 29th, 2022
- Cellular and Molecular Medicine | Faculty of Medicine - October 21st, 2022
- Molecular Diagnostics > Fact Sheets > Yale Medicine - October 21st, 2022
- Expert Reviews in Molecular Medicine | Cambridge Core - October 13th, 2022
- UT Southwestern ranked top health care institution globally for published research by Nature Index - UT Southwestern - October 13th, 2022
- Common Antibiotics Are Losing Their Potency. Researchers Pinpoint Mechanism to Restore It. - NYU Langone Health - October 13th, 2022
- expert reaction to study looking at integrating human stem cell-derived brain-like tissue in the brains of newborn rats - Science Media Centre - October 13th, 2022
- HTG Provides Update on Third Quarter Progress Toward Its Transcriptome-Informed Approach to Drug Discovery - Yahoo Finance - October 13th, 2022
- UVA Discovers Key Driver of High Blood Pressure - UVA Health Newsroom - October 13th, 2022
- Postdoctoral Fellow in Lung Cancer Genomics job with NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY - NTNU | 311727 - Times Higher Education - October 13th, 2022
- Common cold may increase the risk of long Covid - Earth.com - October 13th, 2022
- Caris' Precision Oncology Alliance Welcomes The Cancer Institute at The University of Tennessee Medical Center - PR Newswire - October 13th, 2022
- Merus Announces Publication of Abstract on MCLA-129 at the 34th EORTC/NCI/AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics - Yahoo... - October 13th, 2022
- Molecular Test Could Improve Early Detection of Pancreatic Cancer - Technology Networks - October 13th, 2022
- UTSW researchers identify key player in cellular response to stress - EurekAlert - October 4th, 2022
- New Antibody Demonstrates Therapeutic Benefits Against Alzheimers - SciTechDaily - October 4th, 2022
- Mount Sinai study uncovers mechanisms of reactive oxygen species in stem cell function and inflammation prevention - EurekAlert - October 4th, 2022
- NovoPath Pushes the Limits of Laboratory Information Systems with Integrated Workflows for Genetic and Molecular Testing - PR Newswire - October 4th, 2022
- Postdoctoral Fellow in Bioinformatics job with NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY - NTNU | 311073 - Times Higher Education - October 4th, 2022
- Breast Cancer Awareness | Nick Jacobs | An unlikely partnership: The United States Army Space and Missile Defense Command and the Joyce Murtha Breast... - October 4th, 2022
- Tackling resistance to HIF2 drugs with an RNA-based therapy - UT Southwestern - October 4th, 2022
- OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an adjunct to Cytoreductive Surgery of Peritoneal Carcinomatosis - Business... - October 4th, 2022
- SIMATS organizes Induction Ceremony - Afternoonnews - Afternoon News - October 4th, 2022
- ExPath Grad Student Madeline Mayday Awarded Grant from the NIDDK Cooperative Centers of Excellence in Hematology - Yale School of Medicine - September 25th, 2022
- Blood Cancer Discovery Publication Further Validates Exscientia's AI Precision Medicine Platform for Improving Patient Outcomes - Business Wire - September 25th, 2022
- New Startups Built From UC Davis Innovations Drive Solutions in Food, Health and Agriculture - University of California, Davis - September 25th, 2022
- Scientists Discover New Cancer Treatment - The Morning News - September 25th, 2022
- Rewriting the Textbook for Precision Medicine - Technology Networks - September 25th, 2022
- Biden says 'The pandemic is over,' but health experts disagree - Chief Healthcare Executive - September 25th, 2022
- Discovery Illuminates How Parkinson's Disease Spreads in The Brain - Weill Cornell Medicine Newsroom - September 25th, 2022
- AI Used to Determine Cause of Alzheimer's and Related Disorders - Inside Precision Medicine - September 25th, 2022
- Looking Ahead in the Treatment of Breast Cancer - Targeted Oncology - September 25th, 2022
- Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children - EurekAlert - September 25th, 2022
- New study reveals breakthrough infections increase immunity to COVID-19 - OHSU News - September 25th, 2022
- Coronavirus Today: Who's dying of COVID-19 now? - Los Angeles Times - September 25th, 2022
- Hoag Named Radiopharmaceutical Therapy Center of Excellence, Publishes Results of Breast and Prostate Cancer Trials - PR Newswire - September 8th, 2022
- Orbital Therapeutics Launches to Advance New Frontiers of Science with the Next Generation of Innovative RNA Medicines - Yahoo Finance - September 8th, 2022
- Scientists urged the Biden administration to launch an Operation Warp Speed to develop inhaled COVID vaccines. China beat the U.S. to the punch -... - September 8th, 2022
- Foundation Medicine to Share 14 Abstracts at the 2022 European Society for Medical Oncology (ESMO) Congress Demonstrating the Power of Genomic... - September 8th, 2022
- Monte Rosa Therapeutics Announces FDA Clearance of Investigational New Drug Application for MRT-2359, a GSPT1-directed Molecular Glue Degrader Phase... - September 8th, 2022
- Biden administration says the once-a-year shot phase of the COVID-19 pandemic has arrived - The Boston Globe - September 8th, 2022
- ICCBS welcomes students of MPhil and PhD Programs 2022 - The Academia Mag - September 8th, 2022
- Exciting PhD positions at the European Molecular Biology Laboratory (EMBL) job with EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) | 308114 - Times... - September 8th, 2022
- Congratulations to our NRF award winners | UCT News - University of Cape Town News - September 8th, 2022
- Patients with some forms of aggressive esophageal cancers may benefit from treatment targeting how cells self-regulate - EurekAlert - September 8th, 2022
- Molecular Medicine (M.Sc.) - Georg-August-Universitt Gttingen - August 30th, 2022
- Gradalis Announces Publication in Nature Communications Medicine Identifying Survival Predicting Biomarker in Patients with Ovarian Cancer Treated... - August 30th, 2022
- Feinstein Institutes Get $3M From Lupus Research Alliance to Study Remission and Future Therapies - Business Wire - August 30th, 2022
- Unlocking the Power of Precision Medicine the Rheumatology Example - Technology Networks - August 30th, 2022
- When to trust your covid test results and when to question them | Mint - Mint - August 30th, 2022
- Molecular Diagnostics Market Report 2022-2030: Increasing Adoption of Point-Of-Care (Poc) Testing and the Development of Novel Assays Presents... - August 30th, 2022
- Advancing Precision Oncology, Ochsner Health First to Fully Integrate with Tempus and Epic's Genomics Module - Newswise - August 30th, 2022
- Tiny, Touch-Based Sensor Could Help Patients Stay on Top of Their Medications - SciTechDaily - August 30th, 2022
- Stellar Scholars Join CLAS Faculty - UConn Today - University of Connecticut - August 30th, 2022
- COVID-19 gave new urgency to the science of restoring smell - Science News Magazine - August 30th, 2022
- Dr. Sun lab wins R01 from National Institutes of Health to study liver proteins - Wayne State University - August 22nd, 2022
- Pasithea Therapeutics to Present Results of Tolerizing Vaccine Program at Prestigious International Immunotherapy Conference - GlobeNewswire - August 22nd, 2022
- New Study Identifies How A Group Of Genes Are Linked To Behavioral Conditions - Forbes - August 22nd, 2022
- New gene variant that protects against coronary heart disease uncovered - EurekAlert - August 22nd, 2022
- How a Japanese Herbal Medicine Protects the Gut Against Inflammatory Bowel Disease - Neuroscience News - August 22nd, 2022
- Insilico Medicine presents on AI for drug discovery at 9th Annual Aging Research and Drug Discovery Conference - EurekAlert - August 22nd, 2022
- Why polio is back on the radar of Canadian health officials - Brighter World - August 22nd, 2022
- Angela DeMichele, MD, MSCE, Assesses the Value of I-SPY2 for Neoadjuvant Treatment of Early Breast Cancer - Cancer Network - August 22nd, 2022
- Exciting PhD positions at the European Molecular Biology Laboratory (EMBL) job with EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) | 304753 - Times... - August 22nd, 2022
- Sensor could help patients stay on top of their meds - EurekAlert - August 22nd, 2022
- Trivitron Healthcare launches CoE in metabolomics, genomics, newborn screening and molecular diagnostics - Express Healthcare - August 22nd, 2022
- Research Trends of Moxibustion Therapy for Pain Treatment Over the Pas | JPR - Dove Medical Press - August 22nd, 2022
- Edited Transcript of EXAI.OQ earnings conference call or presentation 18-Aug-22 12:30pm GMT - Yahoo Finance - August 22nd, 2022
- Roche launches COVID-19 test that detects and differentiates the emerging variant of interest BA.2.75 - PR Newswire - August 22nd, 2022
- Will Omicron BA.5 Be the Last of the COVID Variants? - The Epoch Times - August 22nd, 2022
- Many Paths to Failure | Harvard Medical School - Harvard Medical School - August 5th, 2022
- Mitochondrial DNA Mutations Linked to Heart Disease Risk - University of California San Diego - August 5th, 2022
- UC Davis Sets a New Record, Surpasses $1 Billion in Research Funding - University of California, Davis - August 5th, 2022
- A first update on mapping the human genetic architecture of COVID-19 - Nature.com - August 5th, 2022